Showing results (1-10 of 257) with videos related to
Sort By:
Pageof 26
QJM : Monthly Journal of the Association of Physicians|May 1, 2012
Current antiplatelet options for NSTE-ACS patientsG Cayla, J Silvain, S A O'Connor, et al.Annales De Cardiologie Et D'Angeiologie|October 20, 2012
[Management of ST-elevation myocardial infarction in 2012]G Cayla, J Silvain, P Ecollan, et al.International Journal of Cardiology|July 17, 2012
Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD StudyO Barthélémy, G Cayla, J Silvain, et al.Thrombosis and Haemostasis|April 21, 2011
Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure. The AERER studyG Cayla, P Sié, J Silvain, et al.Thrombosis and Haemostasis|August 9, 2013
Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assayJ Abtan, J Silvain, M Kerneis, et al.Heart (British Cardiac Society)|March 23, 2011
Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD StudyG Cayla, J Silvain, O Barthelemy, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|December 22, 1999
[Antithrombotics and interventional cardiology]J P Collet, G MontalescotAnnales De Cardiologie Et D'Angeiologie|August 28, 2007
[Management coronary syndrome in the acute phase]J-P Collet, G MontalescotArchives Des Maladies Du Coeur Et Des Vaisseaux|January 26, 2005
[Does diabetes affect the choice of pharmaceutical treatment in coronary artery disease?]J P Collet, G MontalescotHamostaseologie|November 3, 2009
P2Y12 inhibitors: thienopyridines and direct oral inhibitorsJ-P Collet, G MontalescotPageof 26